New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated ...

Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the ...

To Build Stronger AI, We Need To Better Understand The Human Brain

To this day, in the known universe, only one example exists of a system capable of general-purpose intelligence. That system ...
The Manila Times

Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the ...

YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and ...
Scientific Research Publishing

Research on the Participation Motivations of Users in UGC Society Based on DDCM ()

This study combines satisfaction, achievement motivation, and social identity theories to construct a dynamic discrete choice ...

Ascendis Pharma: Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL ...

YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...